Skip to content

NYSE · CIK 0001369290

MYO MYOMO, INC.

Insider trading from SEC Form 4. Last filing 28 d ago. Close $1.43 on Oct 9, 2026, +123% from the 52-week low and -23% from the high.

Last 90 days

Net insider value
-$41k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$41k by 2 insiders
Insiders on file
8
with a Form 4 at this company

Price and insider trades, last year

MYOOct 9, 2026 · close 1.43

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at MYOMO, INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
28WeakHarry Kovelman
Chief Medical Officer
sell
$20k
15,488 shares
-15%-
23WeakMilton Mayo Morris
director
sell
$21k
15,000 shares
-7%-
31WeakHeather C Getz
director
buy
$14k
20,000 shares
+18%+13% from low-87% from high
50ModerateHeather C Getz
director
buy
$51k
70,000 shares
+168%+5% from low-88% from high
46ModerateThomas F Kirk
director
buy
$5,355
7,437 shares
+2%0% from low-90% from high
44ModerateThomas Aloysius Crowley Jr.
director
buy
$3,233
4,385 shares
+6%0% from low-90% from high
46ModerateThomas F Kirk
director
buy
$58k
50,000 shares
+12%+12% from low-84% from high
41ModerateThomas F Kirk
director
buy
$55k
50,000 shares
+13%+15% from low-84% from high
57ModeratePaul R Gudonis
Chief Executive Officer
buy
$47k
50,000 shares
+4%0% from low-86% from high
61NotablePaul R Gudonis
Chief Executive Officer
buy
$97k
30,000 shares
+3%+1% from low-54% from high
60NotableThomas F Kirk
director
buy
$126k
38,767 shares
+13%+2% from low-54% from high
60NotableThomas F Kirk
director
buy
$168k
50,000 shares
+20%+4% from low-53% from high
21WeakThomas F Kirk
director
buy
$37k
7,400 shares
+3%-
31WeakHarry Kovelman
Chief Medical Officer
sell
$165k
30,000 shares
-23%-

Transactions

The last 46 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026Harry Kovelman
Chief Medical Officer
SOpen-market sale
Common Stock
-15,488$1.27$20k90,24528 d ago
Sep 2, 2026Milton Mayo Morris
director
SOpen-market sale
Common Stock
-15,000$1.41$21k208,39138 d ago
Mar 16, 2026Heather C Getz
director
POpen-market purchase
Common Stock
+20,000$0.70$14k131,754Mar 17, 2026
Mar 12, 2026Heather C Getz
director
POpen-market purchase
Common Stock
+70,000$0.73$51k111,754Mar 12, 2026
Jan 12, 2026Paul R Gudonis
Chief Executive Officer
AGrant or award
Common Stock
+11,637$0.00$01,260,650Jan 14, 2026
Jan 12, 2026David A Henry
Chief Financial Officer
AGrant or award
Common Stock
+8,727$0.00$0436,627Jan 14, 2026
Nov 20, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+4,902$0.72$3,529479,322Nov 24, 2025
Nov 21, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+2,535$0.72$1,825481,857Nov 24, 2025
Nov 18, 2025Thomas Aloysius Crowley Jr.
director
POpen-market purchase
Common Stock
+4,000$0.73$2,93875,748Nov 21, 2025
Nov 19, 2025Thomas Aloysius Crowley Jr.
director
POpen-market purchase
Common Stockindirect: By immediate family memeber of reporting person
+385$0.77$295479Nov 21, 2025
Sep 9, 2025Paul R Gudonis
Chief Executive Officer
GGift
Common Stock
-10,000$0.00$01,249,013Sep 11, 2025
Aug 25, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+50,000$1.15$58k474,420Aug 26, 2025
Aug 18, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+50,000$1.10$55k424,420Aug 19, 2025
Aug 15, 2025Paul R Gudonis
Chief Executive Officer
POpen-market purchase
Common Stock
+50,000$0.95$47k1,259,013Aug 18, 2025
Jun 30, 2025David A Henry
Chief Financial Officer
FTax withholding
Common Stock
-23,587$2.19$52k427,900Jul 2, 2025
Jun 30, 2025Harry Kovelman
Chief Medical Officer
FTax withholding
Common Stock
-13,054$2.19$29k140,618Jul 2, 2025
Jun 11, 2025Micah Mitchell
Chief Commercial Officer
AGrant or award
Common Stock
+59,440$0.00$0199,709Jun 13, 2025
Jun 11, 2025Harry Kovelman
Chief Medical Officer
AGrant or award
Common Stock
+62,938$0.00$0153,672Jun 13, 2025
Jun 11, 2025David A Henry
Chief Financial Officer
AGrant or award
Common Stock
+76,398$0.00$0451,487Jun 13, 2025
Jun 11, 2025Paul R Gudonis
Chief Executive Officer
AGrant or award
Common Stock
+157,342$0.00$01,209,013Jun 13, 2025
Jun 11, 2025Thomas F Kirk
director
AGrant or award
Common Stock
+29,720$0.00$0374,420Jun 12, 2025
Jun 11, 2025Milton Mayo Morris
director
AGrant or award
Common Stock
+29,720$0.00$0144,687Jun 12, 2025
Jun 11, 2025Thomas Aloysius Crowley Jr.
director
AGrant or award
Common Stock
+29,720$0.00$071,748Jun 12, 2025
Jun 11, 2025Heather C Getz
director
AGrant or award
Common Stock
+29,720$0.00$041,754Jun 12, 2025
Jun 6, 2025David A Henry
Chief Financial Officer
FTax withholding
Common Stock
-8,373$2.97$25k375,089Jun 6, 2025
Jun 6, 2025Harry Kovelman
Chief Medical Officer
FTax withholding
Common Stock
-5,743$2.97$17k90,734Jun 6, 2025
May 14, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+1,943$3.25$6,315307,876May 15, 2025
May 15, 2025Paul R Gudonis
Chief Executive Officer
POpen-market purchase
Common Stock
+30,000$3.22$97k1,051,671May 15, 2025
May 15, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+36,824$3.25$120k344,700May 15, 2025
May 12, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+50,000$3.35$168k305,933May 14, 2025
Mar 13, 2025Thomas F Kirk
director
POpen-market purchase
Common Stock
+7,400$5.00$37k255,933Mar 14, 2025
Mar 11, 2025Paul R Gudonis
Chief Executive Officer
AGrant or award
Common Stock
+6,708$0.00$01,021,671Mar 13, 2025
Mar 11, 2025David A Henry
Chief Financial Officer
AGrant or award
Common Stock
+4,106$0.00$0385,481Mar 13, 2025
Mar 11, 2025Harry Kovelman
Chief Medical Officer
AGrant or award
Common Stock
+3,553$0.00$0127,973Mar 13, 2025
Mar 13, 2025David A Henry
Chief Financial Officer
FTax withholding
Common Stock
-2,019$5.22$11k383,462Mar 13, 2025
Mar 12, 2025Harry Kovelman
Chief Medical Officer
SOpen-market sale
Common Stock
-30,000$5.50$165k97,973Mar 13, 2025
Mar 13, 2025Harry Kovelman
Chief Medical Officer
FTax withholding
Common Stock
-1,496$5.22$7,80996,477Mar 13, 2025
Feb 13, 2025Paul R Gudonis
Chief Executive Officer
MOption exercise
Common Stock
+694$0.05$331,014,963Feb 18, 2025
Feb 13, 2025Paul R Gudonis
Chief Executive Officer
MOption exercise
Stock Optionderivative
-694$0.00$00Feb 18, 2025
Jun 9, 2024Paul R Gudonis
Chief Executive Officer
MOption exercise
Common Stock
+6,024$0.00$01,014,269Jan 24, 2025
Jun 9, 2024David A Henry
Chief Financial Officer
MOption exercise
Common Stock
+3,012$0.00$0381,375Jan 24, 2025
Jun 9, 2024Harry Kovelman
Chief Medical Officer
MOption exercise
Common Stock
+1,235$0.00$0124,549Jan 24, 2025
Jun 9, 2024Paul R Gudonis
Chief Executive Officer
MOption exercise
Restricted Stock Unitsderivative
-6,024$0.00$00Jan 24, 2025
Jun 9, 2024David A Henry
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-3,012$0.00$00Jan 24, 2025
Jun 9, 2024Harry Kovelman
Chief Medical Officer
MOption exercise
Restricted Stock Unitsderivative
-1,235$0.00$00Jan 24, 2025
Nov 4, 2024Harry Kovelman
Chief Medical Officer
FTax withholding
Common Stock
-121$3.70$448123,314Nov 5, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

MYO insider trading: MYOMO, INC. | InsiderTell